Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing pramipexole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramipexole (substance) |
Inferred relationship |
Some |
1 |
pramipexol 88 µg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramipexole (substance) |
Inferred relationship |
Some |
|
pramipexol 180 µg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramipexole (substance) |
Inferred relationship |
Some |
|
pramipexol 700 µg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramipexole (substance) |
Inferred relationship |
Some |
|
pramipexoldihydrochlorid tablet 125 µg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramipexole (substance) |
Inferred relationship |
Some |
|
pramipexoldihydrochlorid tablet 250 µg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramipexole (substance) |
Inferred relationship |
Some |
|
pramipexoldihydrochlorid tablet 1 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramipexole (substance) |
Inferred relationship |
Some |
|
pramipexoldihydrochlorid 1,5 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramipexole (substance) |
Inferred relationship |
Some |
|
pramipexoldihydrochlorid 500 µg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramipexole (substance) |
Inferred relationship |
Some |
|
Pramipexole dihydrochloride (substance) |
Is a |
False |
Pramipexole (substance) |
Inferred relationship |
Some |
|
Product containing pramipexole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramipexole (substance) |
Inferred relationship |
Some |
1 |
Pramipexole dihydrochloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Pramipexole (substance) |
Inferred relationship |
Some |
|
Product containing only pramipexole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramipexole (substance) |
Inferred relationship |
Some |
1 |
Product containing only pramipexole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramipexole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pramipexole (as pramipexole dihydrochloride) 3.15 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pramipexole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pramipexole (as pramipexole dihydrochloride) 1.05 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pramipexole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pramipexole (as pramipexole dihydrochloride) 2.1 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pramipexole (substance) |
Inferred relationship |
Some |
1 |
Pramipexole (as pramipexole dihydrochloride) 520 microgram prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pramipexole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pramipexole (as pramipexole dihydrochloride) 260 microgram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pramipexole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pramipexole (as pramipexole dihydrochloride) 88 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pramipexole (substance) |
Inferred relationship |
Some |
1 |
Pramipexole (as pramipexole dihydrochloride) 180 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pramipexole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pramipexole (as pramipexole dihydrochloride) 350 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pramipexole (substance) |
Inferred relationship |
Some |
1 |
Pramipexole (as pramipexole dihydrochloride) 700 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pramipexole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pramipexole (as pramipexole dihydrochloride) 520 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pramipexole (substance) |
Inferred relationship |
Some |
1 |
Pramipexole (as pramipexole dihydrochloride) 1.57 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pramipexole (substance) |
Inferred relationship |
Some |
1 |
Pramipexole (as pramipexole dihydrochloride) 2.62 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pramipexole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pramipexole (as pramipexole dihydrochloride) 1.05 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pramipexole (substance) |
Inferred relationship |
Some |
1 |